AU2005258838B2 - Human autism predisposition gene encoding a transcription factor and uses thereof - Google Patents
Human autism predisposition gene encoding a transcription factor and uses thereof Download PDFInfo
- Publication number
- AU2005258838B2 AU2005258838B2 AU2005258838A AU2005258838A AU2005258838B2 AU 2005258838 B2 AU2005258838 B2 AU 2005258838B2 AU 2005258838 A AU2005258838 A AU 2005258838A AU 2005258838 A AU2005258838 A AU 2005258838A AU 2005258838 B2 AU2005258838 B2 AU 2005258838B2
- Authority
- AU
- Australia
- Prior art keywords
- autism
- gene
- pitx1
- alteration
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58413004P | 2004-07-01 | 2004-07-01 | |
| US60/584,130 | 2004-07-01 | ||
| PCT/IB2005/002319 WO2006003520A2 (en) | 2004-07-01 | 2005-06-30 | Human autism predisposition gene encoding a transcription factor and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2005258838A1 AU2005258838A1 (en) | 2006-01-12 |
| AU2005258838B2 true AU2005258838B2 (en) | 2009-05-14 |
Family
ID=35432082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005258838A Ceased AU2005258838B2 (en) | 2004-07-01 | 2005-06-30 | Human autism predisposition gene encoding a transcription factor and uses thereof |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20070218068A1 (https=) |
| EP (1) | EP1761649B1 (https=) |
| JP (1) | JP4949240B2 (https=) |
| AT (1) | ATE382101T1 (https=) |
| AU (1) | AU2005258838B2 (https=) |
| CA (1) | CA2571365A1 (https=) |
| DE (1) | DE602005004026T2 (https=) |
| ES (1) | ES2299059T3 (https=) |
| IL (1) | IL179751A (https=) |
| WO (1) | WO2006003520A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110118135A1 (en) * | 2008-01-09 | 2011-05-19 | State Matthew W | Mutations in Contaction Associated Protein 2 (CNTNAP2) are Associated with Increased Risk for Ideopathic Autism |
| WO2009150221A1 (en) * | 2008-06-12 | 2009-12-17 | Integragen | A method for autism prediction |
| EP2963129A3 (en) * | 2008-11-12 | 2016-05-11 | University of Utah Research Foundation | Autism associated genetic markers |
| WO2011067296A1 (en) | 2009-12-01 | 2011-06-09 | Integragen | A combination of eight risk alleles associated with autism |
| KR101167942B1 (ko) | 2010-02-12 | 2012-07-23 | 차의과학대학교 산학협력단 | Alg12 유전자로부터 유래된 단일염기다형을 포함하는 폴리뉴클레오티드, 이를 포함하는 마이크로어레이 및 진단키트, 및 이를 이용한 자폐 스펙트럼 장애 분석방법 |
| CA2797319A1 (en) | 2010-05-04 | 2011-11-10 | Integragen | A new combination of eight risk alleles associated with autism |
| EP2860265B1 (en) | 2011-02-24 | 2016-10-26 | The Chinese University of Hong Kong | Determining fetal DNA percentage for twins |
| CN111808943B (zh) * | 2020-06-18 | 2021-07-20 | 重庆浦洛通基因医学研究院有限公司 | 一种精神类个体化用药基因检测方法 |
-
2005
- 2005-06-30 AT AT05764390T patent/ATE382101T1/de active
- 2005-06-30 CA CA002571365A patent/CA2571365A1/en not_active Abandoned
- 2005-06-30 AU AU2005258838A patent/AU2005258838B2/en not_active Ceased
- 2005-06-30 DE DE602005004026T patent/DE602005004026T2/de not_active Expired - Lifetime
- 2005-06-30 ES ES05764390T patent/ES2299059T3/es not_active Expired - Lifetime
- 2005-06-30 JP JP2007519914A patent/JP4949240B2/ja not_active Expired - Fee Related
- 2005-06-30 US US11/570,543 patent/US20070218068A1/en not_active Abandoned
- 2005-06-30 EP EP05764390A patent/EP1761649B1/en not_active Expired - Lifetime
- 2005-06-30 WO PCT/IB2005/002319 patent/WO2006003520A2/en not_active Ceased
-
2006
- 2006-11-30 IL IL179751A patent/IL179751A/en not_active IP Right Cessation
Non-Patent Citations (1)
| Title |
|---|
| SHASTRY B S: "Molecular genetics of autism disorders" Journal of Human genetics, vol. 48, no. 10, 2003, pages 495-501. * |
Also Published As
| Publication number | Publication date |
|---|---|
| DE602005004026T2 (de) | 2008-12-24 |
| EP1761649A2 (en) | 2007-03-14 |
| ES2299059T3 (es) | 2008-05-16 |
| EP1761649B1 (en) | 2007-12-26 |
| WO2006003520A2 (en) | 2006-01-12 |
| CA2571365A1 (en) | 2006-01-12 |
| IL179751A0 (en) | 2007-05-15 |
| US20070218068A1 (en) | 2007-09-20 |
| JP4949240B2 (ja) | 2012-06-06 |
| WO2006003520A3 (en) | 2006-03-02 |
| JP2008504837A (ja) | 2008-02-21 |
| DE602005004026D1 (de) | 2008-02-07 |
| IL179751A (en) | 2011-01-31 |
| ATE382101T1 (de) | 2008-01-15 |
| AU2005258838A1 (en) | 2006-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20100240539A1 (en) | Human Autism Susceptibility Gene Encoding PRKCB1 and Uses Thereof | |
| EP1656458B1 (en) | Human autism susceptibility gene and uses thereof | |
| AU2005258838B2 (en) | Human autism predisposition gene encoding a transcription factor and uses thereof | |
| AU2006215385B2 (en) | Uses of human autism susceptibility gene encoding a kinase | |
| US20080213765A1 (en) | Human Autism Susceptibility Genes Encoding a Neurotransmitter Transporter and Uses Thereof | |
| AU2006225995B2 (en) | Human autism susceptibility gene encoding a transmembrane protein and uses thereof | |
| AU2005254806B2 (en) | Human obesity susceptibility gene encoding a potassium voltage-gated channel and uses thereof | |
| WO2006003526A2 (en) | Human autism susceptibility gene encoding otoa and uses thereof | |
| CA2586092A1 (en) | Human obesity susceptibility gene encoding a member of the neurexin family and uses thereof | |
| US20080286765A1 (en) | Human Obesity Susceptibility Gene Encoding a Taste Receptor and Uses Thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |